July 14 (Reuters) - BAYER AG BAYGn.DE:
U.S. FDA APPROVES FINERENONE FOR NEW INDICATION IN PATIENTS WITH HEART FAILURE WITH LEFT VENTRICULAR EJECTION FRACTION OF ≥ 40%
FURTHER REGULATORY APPLICATIONS TO HEALTH AUTHORITIES IN OTHER MARKETS WORLDWIDE HAVE BEEN FILED OR WILL FOLLOW
Further company coverage: [BAYGn.DE]